Open Menu Close Menu

For research in pancreatic cancer that includes a Phase II treatment clinical trial or a robust prevention, detection/diagnosis/prognosis or supportive care trial implemented no later than the beginning of the second year of the grant term. At least two institutions must be involved in the project, and the impact on pancreatic cancer patients should be immediate, if not as soon as possible. Grant payments are triggered by proof of subject enrollment and trial participation.